Financial reports
10-Q
2024 Q3
Quarterly report
15 Apr 24
10-Q
2024 Q2
Quarterly report
16 Jan 24
10-Q
2024 Q1
Quarterly report
16 Oct 23
10-K
2023 FY
Annual report
1 Sep 23
NT 10-K
Notice of late annual filing
29 Aug 23
10-Q
2023 Q3
Quarterly report
29 Jun 23
10-Q
2023 Q2
Quarterly report
19 May 23
10-Q
2023 Q1
Quarterly report
19 Apr 23
10-K
2022 FY
Annual report
7 Apr 23
NT 10-K
Notice of late annual filing
29 Aug 22
Current reports
8-K
Unregistered Sales of Equity Securities
4 Apr 24
8-K
Cell MedX Corp. Closes Private Placement Financing
19 Mar 24
8-K
Cell MedX Corp. Announces Resignation of Director
28 Feb 24
8-K
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
19 Dec 23
8-K
Cell Medx Corp. Announces Full Revocation of British Columbia Cease Trade Order
27 Nov 23
8-K
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer
13 Nov 23
8-K
Cell MedX Amends Loan Agreements, Provides Update on Financing and Regulatory Compliance
18 Oct 22
8-K
Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director
27 Apr 22
8-K
Entry into a Material Definitive Agreement
26 May 21
8-K
Cell MedX Corp. (CMXC) Announces a Non-Brokered Private Placement Financing
4 Aug 20
Registration and prospectus
D
$120.00 k in equity / options / securities to be acquired, sold $45.00 k, 2 investors
26 Mar 24
424B3
Prospectus supplement
14 Oct 21
424B3
Prospectus supplement
12 Oct 21
D
$5K in equity, sold $5K, 1 investor
2 Aug 21
D
$5K in equity, sold $5K, 1 investor
8 Jul 21
424B3
Prospectus supplement
27 May 21
424B3
Prospectus supplement
9 Apr 21
424B3
Prospectus supplement
15 Mar 21
S-1
IPO registration
4 Mar 21
D
$246K in equity / options / securities to be acquired, sold $82K, 6 investors
18 Nov 20
Other
EFFECT
Notice of effectiveness
15 Mar 21
CORRESP
Correspondence with SEC
10 Mar 21
UPLOAD
Letter from SEC
9 Mar 21
CORRESP
Correspondence with SEC
3 Jun 11
EFFECT
Notice of effectiveness
3 Jun 11
CORRESP
Correspondence with SEC
2 Jun 11
UPLOAD
Letter from SEC
22 Mar 11
UPLOAD
Letter from SEC
24 Feb 11
CORRESP
Correspondence with SEC
14 Oct 10
UPLOAD
Letter from SEC
10 Aug 10